The startup is developing “modified DNA” therapies it claims can combine the strengths of multiple approaches, from messenger ...

Paraxanthine is the metabolite the human liver produces when it breaks down caffeine. Recent peer-reviewed research identifies paraxanthine as the molecule responsible for much of caffeine's cognitive ...

A biotech startup founded by three scientists from a Nobel laureate's Stanford laboratory has raised $4.8 million in seed ...

Anthropic has purchased the stealth biotech AI startup Coefficient Bio in a $400 million stock deal, according to The Information and Eric Newcomer.

Just a few years ago, Daniel Chen, M.D., Ph.D., was spending his spare time in his backyard, sketching out designs for new ...

10x Science, founded in December 2025, has secured $4.8 million in seed funding led by Initialized Capital to address a key ...

What did Eli Lilly see in a struggling biotech startup that made the pharma giant want to pay billions for it? Bryan Roberts ...

Artificial intelligence and biotech are two of the sectors that have been able to buck the current sluggish pace of venture capital spending. So it’s not surprising a startup at the intersection of ...

A slow start to 2026 has put first-time biotech financings on course for their worst year since before the pandemic, reducing ...

When Neal Piper’s son, Noah, rang the bell at UVA Children’s Hospital in December 2020, it signaled the end of grueling chemotherapy treatments connected to beeping monitors and intravenous tubes.

Dr. Vivek Anand Oberoi, serial entrepreneur, philanthropist and award-winning actor, is sharpening his focus on impact-driven ...